Early intervention in schizophrenia: three frameworks for guiding ethical inquiry
Psychiatric research is making important strides toward early detection and treatment of schizophrenia. Discovery of genetic markers, identifiable prodromes, and low-risk interventions fuel this vital scientific movement. At the same time, investigators and clinicians are studying the ethical questions that arise whenever the bounds of diagnosis and treatment are evolving rapidly. This ethical analysis generally falls within three dominant frameworks of bioethics: the conceptualization of disease, scientific uncertainty, and risk-factor ethics. These frameworks are explored as potential guides for directing ethical inquiry in early intervention.
KeywordsBioethics Intervention Genetic markers Risk factors
The author's work in research ethics is supported by an NIH Career Development Award (NIH K01MH01850). The opinions expressed do not necessarily reflect those of the NIH.
- Beresford EB (1991) Uncertainty and the shaping of medical decisions, Hastings Center Report, July–August, pp 6–11Google Scholar
- Brett AS (1984) Ethical issues in risk factor intervention. Am J Med 78:557–561Google Scholar
- Dyer AR (1988) Ethics and psychiatry: toward professional definition. American Psychiatric Press, Washington D.C., Introduction, Chapter 1Google Scholar
- Friedman RC, Downey JI (1997) De-diseasing homosexuality. In: Edwards RB (ed) Ethics of psychiatry. Prometheus Books, Amherst, N.Y., pp 136–155Google Scholar
- King LS (1982) Medical thinking: a historical preface. Princeton University Press, Princeton N.J., p 139Google Scholar
- McGlashan TH, Miller TJ, Woods SW (2000) Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull 27:563–570Google Scholar
- McGorry PD, Phillips LJ, Yung AR, Yuen HP (2001a) Predictors of psychosis: identifying young people at risk. Schizophr Res 49:6Google Scholar
- Stanley B, Stanley M, Peaselow E, Wolkin A, Deutsch S, Platt L, Speicher J, Golash L, Kaufman M (1982) The effects of psychotropic drugs on informed consent. Psychopharmacol Bull 18:102–104Google Scholar
- Warner R (2000) The prevention of schizophrenia: what interventions are safe and effective? Schizophr Bull 27:551–562Google Scholar